GO:0106121 positive regulation of cobalamin catabolic process: Vitamin B12 Turnover, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106121 describes any process that activates or increases the frequency, rate or extent of cobalamin (vitamin B12) catabolic process.
• Cobalamin catabolism and its positive regulation shape the availability of B12-derived cofactors and influence one-carbon metabolism, which is linked to inflammation and fibrosis in metabolic liver disease.
• Microbial communities in the gut can shift their composition and metabolic activity in response to cobalamin, indirectly affecting cobalamin catabolic flux.
• Cobalamin transport and processing proteins such as cubam and MRP1 are upregulated in chronic inflammatory enteropathy, indicating that cobalamin handling is dynamically regulated in disease.
• Vitamin B12 status correlates with telomere length and fetal growth, suggesting that cobalamin catabolic regulation has systemic consequences beyond classical cofactor roles.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect which genes causally regulate cobalamin catabolic process.
Description
Cobalamin (vitamin B12) is an essential micronutrient that serves as a cofactor for methionine synthase and methylmalonyl-CoA mutase, and its catabolic processing determines the availability of active B12 forms in cells and tissues. The Gene Ontology term GO:0106121, positive regulation of cobalamin catabolic process, captures the regulatory inputs that increase the rate or extent of cobalamin breakdown. Understanding this term is important because cobalamin catabolism intersects with one-carbon metabolism, homocysteine clearance, and microbial community dynamics in the gut. Dysregulated cobalamin handling has been associated with metabolic liver disease, inflammatory enteropathy, and altered fetal growth, making the positive regulation of cobalamin catabolic process a research area with translational relevance. At the molecular level, cobalamin catabolic process is influenced by transport proteins, intracellular processing enzymes, and the availability of B12 derivatives. For example, vitamin B12 and folate supplementation decrease inflammation and fibrosis in nonalcoholic steatohepatitis by preventing syntaxin 17 homocysteinylation, a mechanism that depends on cobalamin-dependent one-carbon flux. In the gut, cobalamin exposure shifts microbial composition and metabolic activity in in vitro colon simulations, suggesting that microbial cobalamin catabolism is a regulated community-level trait. These findings highlight that positive regulation of cobalamin catabolic process is not a single enzymatic step but a network of transport, enzymatic, and microbial factors. For researchers, GO:0106121 provides a structured framework to annotate genes and pathways that enhance cobalamin catabolism. Because cobalamin catabolic process is tightly linked to cofactor supply, any positive regulator can alter methionine synthesis, methylmalonyl-CoA handling, and downstream epigenetic or redox states. This article summarizes the definition, core mechanisms, key genes, disease links, and experimental models relevant to GO:0106121, with an emphasis on CRISPR-based approaches for causal validation.
positive regulation of cobalamin catabolic process At A Glance
| GO ID | GO:0106121 |
|---|---|
| GO term | positive regulation of cobalamin catabolic process |
| Ontology | biological_process |
| Synonym | none |
| Major function | Activates or increases the frequency, rate or extent of cobalamin (vitamin B12) catabolic process |
| Parent term | positive regulation of catabolic process |
| Related molecule | Cobalamin (vitamin B12) |
| Related process | Cobalamin catabolic process |
| Taxon scope | All organisms with cobalamin catabolism |
What Is GO:0106121?
GO:0106121, positive regulation of cobalamin catabolic process, is a biological process term defined as any process that activates or increases the frequency, rate or extent of a cobalamin (vitamin B12) catabolic process. In other words, it describes the regulatory events that promote the breakdown or turnover of cobalamin, rather than the catabolic reaction itself. This term is a child of positive regulation of catabolic process and is specific to cobalamin, distinguishing it from general vitamin or cofactor catabolism.
Why Is positive regulation of cobalamin catabolic process Important in Cell Biology?
Positive regulation of cobalamin catabolic process is important because cobalamin catabolism controls the cellular pool of active B12 cofactors, which are required for methionine synthase and methylmalonyl-CoA mutase activities. Perturbations in this regulation can alter one-carbon metabolism, homocysteine levels, and downstream inflammatory and fibrotic pathways, as shown in nonalcoholic steatohepatitis where vitamin B12 and folate decrease inflammation and fibrosis by preventing syntaxin 17 homocysteinylation. In the gut, cobalamin-induced shifts in microbial composition and metabolic activity demonstrate that cobalamin catabolic regulation extends to host-microbe interactions. Furthermore, cobalamin transport proteins such as cubam and MRP1 are upregulated in chronic inflammatory enteropathy, indicating that cobalamin handling is dynamically regulated in disease states. Therefore, understanding GO:0106121 has implications for metabolic liver disease, inflammatory bowel disease, fetal development, and aging biology.
• Cobalamin catabolic regulation determines the availability of active B12 cofactors for methionine synthase and methylmalonyl-CoA mutase.
• Positive regulation of cobalamin catabolism can influence homocysteine clearance and prevent protein homocysteinylation, as seen in NASH models.
• Gut microbial communities respond to cobalamin by shifting composition and metabolic activity, linking GO:0106121 to microbiome-host interactions.
• Cobalamin transport and processing proteins are upregulated in chronic inflammatory enteropathy, suggesting disease-associated remodeling of cobalamin catabolism.
• Vitamin B12 status is associated with telomere length, implicating cobalamin catabolic regulation in cellular aging.
• Active vitamin B12 forms improve fetal growth in rats through upregulation of placental miR-16 and miR-21, connecting cobalamin catabolism to developmental outcomes.
• Serum nickel and homocysteine relationships in hemodialysis patients highlight trace-element interactions with cobalamin-dependent pathways.
• CRISPR screens can identify positive regulators of cobalamin catabolic process, enabling causal gene discovery.
• Microbial and genetic resources for cobalamin biosynthesis provide a comparative framework for understanding catabolic regulation.
• Targeting positive regulators of cobalamin catabolism may offer therapeutic strategies for metabolic and inflammatory diseases.
What Happens During positive regulation of cobalamin catabolic process?
Cobalamin uptake and intracellular delivery
In simple terms: First, vitamin B12 must get into the cell before it can be broken down.
Cobalamin enters cells through transport proteins such as cubam (cubilin-amnionless) and MRP1, which are expressed in the ileum and other tissues. Positive regulation of cobalamin catabolic process can begin with increased expression or activity of these transporters, raising intracellular cobalamin levels available for catabolism. In chronic inflammatory enteropathy, cubam and MRP1 are upregulated, suggesting that transport capacity is dynamically regulated in disease. This step is a prerequisite for subsequent catabolic processing.
Conversion to active cobalamin forms
In simple terms: The cell converts B12 into its usable forms, which can then be broken down or used.
Cobalamin must be converted to active forms such as methylcobalamin and adenosylcobalamin to serve as cofactors. Positive regulation of cobalamin catabolic process may involve enzymes that interconvert these forms, thereby influencing the balance between utilization and catabolism. Active vitamin B12 forms have been shown to improve fetal growth in rats through upregulation of placental miR-16 and miR-21, indicating that the availability of active forms is biologically consequential. The regulation of these conversion steps is therefore central to GO:0106121.
Catabolic processing and cofactor release
In simple terms: The B12 molecule is broken down, and its parts are either recycled or excreted.
Cobalamin catabolic process involves enzymatic cleavage of the corrin ring or its side chains, releasing cobalt and other metabolites. Positive regulation of this process increases the rate of breakdown, potentially reducing the pool of active cobalamin. In nonalcoholic steatohepatitis, vitamin B12 and folate decrease inflammation and fibrosis by preventing syntaxin 17 homocysteinylation, a mechanism that depends on cobalamin-dependent one-carbon metabolism. Thus, catabolic regulation can indirectly affect homocysteine handling and fibrotic signaling.
Microbial cobalamin catabolism in the gut
In simple terms: Gut bacteria also break down B12, and this can be influenced by the host and diet.
Cobalamin-induced shifts in microbial composition and metabolic activity have been observed in in vitro colon simulations, indicating that microbial cobalamin catabolism is a regulated process. Positive regulation of cobalamin catabolic process in the microbiome can alter short-chain fatty acid production and other metabolites. Intestinal epithelial Syndecan-1 maintains mucosal homeostasis in inflammatory bowel disease by enhancing Faecalibacterium prausnitzii biofilm formation, a microbe that may interact with cobalamin metabolism. These findings link GO:0106121 to host-microbe symbiosis.
Feedback and systemic consequences
In simple terms: When B12 breakdown changes, it affects many body systems, including blood, nerves, and liver.
Positive regulation of cobalamin catabolic process can lead to reduced cobalamin availability, affecting methionine synthase activity and homocysteine levels. Elevated homocysteine has been linked to nickel status in hemodialysis patients, suggesting trace-element interactions with cobalamin pathways. Vitamin B12 status also correlates with telomere length, indicating long-term consequences for cellular aging. Therefore, regulatory inputs that increase cobalamin catabolism can have systemic effects on metabolism, inflammation, and development.
Key Genes Involved in GO:0106121 positive regulation of cobalamin catabolic process
The following genes and proteins are involved in cobalamin transport, processing, and catabolic regulation, based on published literature relevant to GO:0106121.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CUBN | Cubilin, part of cubam receptor for cobalamin uptake | Upregulated in chronic inflammatory enteropathy |
| AMN | Amnionless, part of cubam receptor | Required for cubam function in cobalamin transport |
| ABCC1 | MRP1, multidrug resistance protein 1, cobalamin efflux | Upregulated in canine ileum in chronic enteropathy |
| MTR | Methionine synthase, cobalamin-dependent enzyme | Central to one-carbon metabolism and homocysteine clearance |
| MUT | Methylmalonyl-CoA mutase, adenosylcobalamin-dependent | Cobalamin cofactor utilization |
| MMACHC | Cobalamin processing enzyme | Intracellular cobalamin trafficking and catabolism |
| MMADHC | Cobalamin processing enzyme | Intracellular cobalamin trafficking |
| TCN2 | Transcobalamin II, plasma cobalamin transport | Delivers cobalamin to tissues |
| TCN1 | Haptocorrin, cobalamin binding in saliva | Cobalamin sequestration and transport |
| FUT2 | Fucosyltransferase 2, affects gut microbial composition | Indirectly influences cobalamin catabolism by microbiota |
| SDC1 | Syndecan-1, intestinal epithelial homeostasis | Enhances F. prausnitzii biofilm, may affect cobalamin metabolism |
| MIR16 | miR-16, placental microRNA | Upregulated by active B12 forms, affects fetal growth |
| MIR21 | miR-21, placental microRNA | Upregulated by active B12 forms, affects fetal growth |
| STX17 | Syntaxin 17, involved in autophagy | Homocysteinylation prevented by B12/folate in NASH |
| NNT | Nicotinamide nucleotide transhydrogenase | Redox balance affecting cobalamin metabolism |
| SLC46A1 | Proton-coupled folate transporter | Folate transport, interacts with B12 metabolism |
| MTHFR | Methylenetetrahydrofolate reductase | Folate cycle, interacts with cobalamin-dependent methionine synthase |
How Is positive regulation of cobalamin catabolic process Regulated?
Positive regulation of cobalamin catabolic process is controlled by multiple layers of regulation. Transcriptional upregulation of cobalamin transporters such as cubam and MRP1 occurs in chronic inflammatory enteropathy, indicating that inflammatory signaling can increase cobalamin handling capacity. At the metabolic level, the availability of active cobalamin forms regulates their own catabolism through feedback loops involving methionine synthase and methylmalonyl-CoA mutase. In the gut, microbial community composition shifts in response to cobalamin, suggesting that microbial catabolic regulation is influenced by host diet and epithelial factors such as Syndecan-1. Additionally, homocysteine levels, which are influenced by cobalamin-dependent one-carbon metabolism, can modulate catabolic flux through allosteric and redox mechanisms. These regulatory inputs collectively determine the rate of cobalamin catabolic process.
positive regulation of cobalamin catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTR | NASH, homocysteine metabolism | Liver-specific knockout in mice |
| CUBN | Chronic inflammatory enteropathy | Intestinal epithelial knockout |
| ABCC1 | Inflammatory bowel disease | MRP1 knockout organoids |
| MIR16 | Fetal growth restriction | Placental overexpression in rats |
| SDC1 | IBD, mucosal homeostasis | Intestinal knockout and microbiome analysis |
Nonalcoholic steatohepatitis (NASH)
Vitamin B12 and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation, a process dependent on cobalamin-dependent one-carbon metabolism. Positive regulation of cobalamin catabolic process could reduce the availability of active B12, potentially exacerbating homocysteine accumulation and liver injury. Therefore, genes that increase cobalamin catabolism may be risk modifiers in NASH.
Chronic inflammatory enteropathy
Expression of cobalamin transporters cubam and MRP1 is upregulated in the canine ileum in chronic inflammatory enteropathy, indicating that cobalamin handling is altered in disease. This upregulation may reflect a compensatory response to inflammation or altered microbial cobalamin catabolism. Positive regulation of cobalamin catabolic process in the gut could influence mucosal healing and microbial homeostasis.
Fetal growth restriction
Combination of vitamin B12 active forms improved fetal growth in Wistar rats through up-regulation of placental miR-16 and miR-21 levels. This suggests that cobalamin catabolic regulation affects placental function and developmental outcomes. Positive regulators of cobalamin catabolism might reduce active B12 availability and impair fetal growth.
Aging and telomere maintenance
Telomere length is associated with vitamin B12 status, linking cobalamin metabolism to cellular aging. Positive regulation of cobalamin catabolic process could deplete active B12 pools, potentially accelerating telomere shortening. However, causal relationships remain to be established through genetic models.
From positive regulation of cobalamin catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate cobalamin catabolism? | CRISPR knockout in cell lines followed by cobalamin metabolite profiling |
| Does a point mutation in a cobalamin transporter alter catabolic flux? | Point-mutation knock-in using CRISPR |
| Can overexpression of a candidate gene increase cobalamin breakdown? | CRISPRa or cDNA overexpression |
| What is the tissue-specific role of a cobalamin catabolic regulator? | Conditional knockout mouse |
| How does a tagged cobalamin enzyme localize during catabolism? | Endogenous knock-in of fluorescent tag |
| Which genes are essential for cobalamin catabolism in the gut microbiome? | CRISPR library screening in microbial communities |
How to Study the positive regulation of cobalamin catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Cobalamin and catabolic intermediates | Quantify catabolic rate in knockout cells |
| RNA-seq | Transcript levels of cobalamin-related genes | Identify transcriptional regulators |
| 16S rRNA sequencing | Microbial composition | Assess cobalamin-induced shifts |
| CRISPR knockout screen | Gene essentiality for cobalamin catabolism | Discover positive regulators |
| CRISPR activation screen | Gene overexpression effects | Identify enhancers of catabolism |
| Western blot | Protein levels of transporters | Validate cubam/MRP1 upregulation |
| Homocysteine assay | Homocysteine concentration | Assess one-carbon flux |
| Telomere length assay | Telomere length | Link B12 status to aging |
Metabolomics and cobalamin profiling
Mass spectrometry-based metabolomics can quantify cobalamin and its catabolic intermediates to assess the rate of cobalamin catabolic process. This method is used to compare wild-type and CRISPR knockout cells to identify positive regulators.
Transcriptomics and RNA-seq
RNA sequencing measures expression changes in cobalamin transporters and processing enzymes, such as CUBN, AMN, and ABCC1, under conditions that modulate catabolism. It helps identify transcriptional programs that positively regulate cobalamin catabolic process.
Microbiome sequencing
16S rRNA or metagenomic sequencing of gut microbial communities reveals shifts in composition in response to cobalamin, as seen in in vitro colon simulations. This approach links microbial cobalamin catabolism to host health.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes whose loss or gain alters cobalamin catabolic flux. Hits are validated by targeted metabolomics and phenotypic assays.
How CRISPR Can Be Used to Study GO:0106121 positive regulation of cobalamin catabolic process
Knockout
CRISPR knockout of candidate genes such as CUBN, AMN, or ABCC1 can test whether they are required for positive regulation of cobalamin catabolic process. Loss-of-function models show reduced catabolic flux if the gene is a positive regulator.
Point Mutation
Point mutations in cobalamin processing enzymes like MMACHC can mimic human disease variants and reveal how specific residues affect catabolic regulation. CRISPR prime editing or HDR-based knock-in introduces these mutations.
Knock-in
Knock-in of fluorescent or epitope tags at endogenous loci allows visualization and immunoprecipitation of cobalamin catabolic proteins. This helps determine their localization and interaction partners during catabolism.
Overexpression
CRISPR activation or cDNA overexpression of candidate genes can test sufficiency for increasing cobalamin catabolic process. Overexpression of transporters or enzymes may enhance catabolic flux and alter downstream metabolites.
How EDITGENE Supports positive regulation of cobalamin catabolic process Research
Researchers studying positive regulation of cobalamin catabolic process-related genes often need to determine whether a candidate gene is causally involved in cobalamin breakdown or merely correlated with it. EDITGENE provides CRISPR-based cell model services to enable such causal experiments, from knockout to precise point mutations and overexpression.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cobalamin catabolic process research.
Frequently Asked Questions About positive regulation of cobalamin catabolic process
What is GO:0106121?
GO:0106121 is the Gene Ontology term for positive regulation of cobalamin catabolic process, defined as any process that activates or increases the frequency, rate or extent of cobalamin (vitamin B12) catabolic process.
What genes are involved in positive regulation of cobalamin catabolic process?
Genes involved include CUBN, AMN, ABCC1, MTR, MUT, MMACHC, MMADHC, TCN2, and TCN1, based on their roles in cobalamin transport and processing.
How is cobalamin catabolic process regulated?
It is regulated by transcriptional control of transporters such as cubam and MRP1, feedback from active cobalamin forms, and microbial community interactions.
What diseases are linked to cobalamin catabolism?
Nonalcoholic steatohepatitis, chronic inflammatory enteropathy, fetal growth restriction, and aging-related telomere shortening have been linked to cobalamin metabolism.
How can I study positive regulation of cobalamin catabolic process?
CRISPR knockout, point mutation, knock-in, overexpression, metabolomics, RNA-seq, and microbiome sequencing are common approaches.
What is the role of vitamin B12 in NASH?
Vitamin B12 and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation.
Does the gut microbiome affect cobalamin catabolism?
Yes, cobalamin induces shifts in microbial composition and metabolic activity in in vitro colon simulations.
What is the relationship between vitamin B12 and telomere length?
Telomere length is associated with vitamin B12 status, suggesting a link between cobalamin metabolism and cellular aging.
Which transporters are involved in cobalamin uptake?
Cubam (cubilin-amnionless) and MRP1 are key transporters, and they are upregulated in chronic inflammatory enteropathy.
Can CRISPR screens identify regulators of cobalamin catabolism?
Yes, genome-wide CRISPR knockout or activation screens can identify genes that positively regulate cobalamin catabolic process.
Conclusion
GO:0106121, positive regulation of cobalamin catabolic process, represents a critical regulatory node that controls vitamin B12 availability and downstream one-carbon metabolism. Dysregulation of this process has been implicated in metabolic liver disease, inflammatory enteropathy, fetal growth, and aging. Understanding the genes and mechanisms that positively regulate cobalamin catabolism requires causal experiments using CRISPR-based models. EDITGENE provides comprehensive services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics, to accelerate research on this important biological process.
References
- 1. Tripathi M et al.. 2022. Vitamin B(12) and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation.. J Hepatol 77(5):1246-1255 PMID: 35820507
- 2. Xu Y et al.. 2018. Cobalamin (Vitamin B12) Induced a Shift in Microbial Composition and Metabolic Activity in an in vitro Colon Simulation.. Front Microbiol 9:2780 PMID: 30505299
- 3. Katko M et al.. 2008. Relationship between serum nickel and homocysteine concentration in hemodialysis patients.. Biol Trace Elem Res 124(3):195-205 PMID: 18465090
- 4. Praveen G et al.. 2022. Telomere length and vitamin B12.. Vitam Horm 119:299-324 PMID: 35337624
- 5. Chen S et al.. 2026. Intestinal epithelial Syndecan-1 maintains mucosal homeostasis in inflammatory bowel disease by enhancing Faecalibacterium prausnitzii biofilm formation.. Gut Microbes 18(1):2665870 PMID: 42068031
- 6. Shah T et al.. 2017. Combination of vitamin B12 active forms improved fetal growth in Wistar rats through up-regulation of placental miR-16 and miR-21 levels.. Life Sci 191:97-103 PMID: 29032242
- 7. Balabanova L et al.. 2021. Microbial and Genetic Resources for Cobalamin (Vitamin B12) Biosynthesis: From Ecosystems to Industrial Biotechnology.. Int J Mol Sci 22(9) PMID: 33926061
- 8. Kather S et al.. 2024. Expression of the cobalamin transporters cubam and MRP1 in the canine ileum-Upregulation in chronic inflammatory enteropathy.. PLoS One 19(1):e0296024 PMID: 38206981
